Cargando…
Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey
BACKGROUND: Coronavirus disease 2019 (COVID-19) pandemic is still evolving globally, and Brazil is currently one of the most affected countries. It is still debated whether patients with inflammatory bowel disease (IBD) are at a higher risk for developing COVID-19 or its complications. AIM: To asses...
Autores principales: | Queiroz, Natália Sousa Freitas, Teixeira, Fábio Vieira, Motta, Marina Pamponet, Chebli, Liliana Andrade, Hino, Adriano Akira Ferreira, Martins, Camilla de Almeida, Quaresma, Abel Botelho, da Silva, Alexandre Augusto de Paula, Damião, Adérson Omar Mourão Cintra, Saad-Hossne, Rogerio, Kotze, Paulo Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006093/ https://www.ncbi.nlm.nih.gov/pubmed/33828396 http://dx.doi.org/10.3748/wjg.v27.i12.1226 |
Ejemplares similares
-
How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician
por: Chebli, Júlio Maria Fonseca, et al.
Publicado: (2021) -
Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study
por: Perin, Ramir Luan, et al.
Publicado: (2022) -
Exploring the Relationship between Biologics and Postoperative Surgical Morbidity in Ulcerative Colitis: A Review
por: Quaresma, Abel Botelho, et al.
Publicado: (2021) -
A guide to preparation of patients with inflammatory bowel diseases for anti-TNF-α therapy
por: Chebli, Júlio Maria Fonseca, et al.
Publicado: (2014) -
Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients
por: Martins, Camilla de Almeida, et al.
Publicado: (2023)